3rik: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 3rik is ON HOLD | The entry 3rik is ON HOLD until Paper Publication | ||
Authors: Orwig, S.D., Lieberman, R.L. | Authors: Orwig, S.D., Lieberman, R.L. | ||
Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease | Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease | ||
Revision as of 19:15, 22 June 2011
Unreleased structure
The entry 3rik is ON HOLD until Paper Publication
Authors: Orwig, S.D., Lieberman, R.L.
Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease